Design and Evaluation of Fast Dissolving Tablets a Novel Natural Superdisintegrant is used in the Development of a BCS Class -II Drug

Author:

Sekhar Naik D. Chandra1,Bharathi A.2

Affiliation:

1. Krishna University, Machilipatnam, Machilipatnam, Andhra Pradesh - 521003, India.

2. KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh - 520004, India.

Abstract

The main objective of the present investigation was to develop fast dissolving tablets for aceclofenac employing Ocimum gratissimum mucilage, a novel superdisintegrant by using 23factorial design. The mucilage was extracted from the seeds of Ocimum gratissimum and tested for flow properties. The senior development of fast dissolving tablets of Aceclofenac with novel natural mucilage as a superdisinitegrant in different ratios (0-5%) by using the direct compression method and Pre-compression and post-compression characteristics like water absorption (percent) and percent of drug dissolved at 5 min were evaluated for all of the formulated fast dissolving tablets. In all acceptable solvents and buffers, the mucilage powder was found to be a fine, free-flowing amorphous powder with good swelling properties. According to the FTIR and DSC investigations, there were no interactions between aceclofenac and the novel natural mucilage powder. In terms of drug content (98.0±0.14 to 99.9±0.05), hardness (3.8±0.03to 3.9±0.31), and friability (0.11±0.012 to 0.12±0.79), all of the formulation batches are of excellent quality. The batch with the improved formulation had a shorter disintegrant time (27±0.83). The improved formulation F2 has a shorter In–Vitro wetting time (19±0.69). The designed tablets' water absorption ratio was determined to be within the limit at (392.1±0.81). In 10 minutes, the cumulative drug dissolved in the optimised formulation F2 was determined to be (99.93%). As an outcome, it could be used in the formulation of fast dissolving tablets to provide an immediate release of the contained drug within 5 minutes.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3